Media
News & Events
Asceneuron to Provide Update on O-GlcNAcase Pipeline
Asceneuron to Provide Update on O-GlcNAcase Pipeline at Upcoming Conferences
WHO report on the public health response to dementia
The World Health Organization has published a "Global status report on the public health response to dementia" where it takes stock of actions driven by Member States, WHO and civil society since the adoption of the global action plan, identifies barriers to its implementation especially in light of the COVID-19 pandemic, and highlights areas where urgent, accelerated action is required.
Asceneuron to present at ANA21 virtual meeting
Asceneuron will present at the next ANA21 virtual meeting organized by the American Neurological Association on October 17-19, 2021.
International Conference on Alzheimer's Drug Discovery
Asceneuron to present at the 22nd International Conference on Alzheimer’s Drug Discovery be held online October 4-5, 2021.
A brighter future for Alzheimer's?
Asceneuron’s unique approach to treat Alzheimer’s disease featured by our CEO Dirk Beher in series of interviews with industry leaders on the future of Alzheimer's disease drug development.
Asceneuron CEO Dirk Beher to speak at AAIC 2021
Asceneuron CEO Dirk Beher to speak at Alzheimer’s Association International Conference
Asceneuron Appoints Catherine Moukheibir to its Board of Directors
Asceneuron Appoints Prominent Healthcare Leader Catherine Moukheibir to its Board of Directors
Asceneuron awarded by the Alzheimer’s Drug Discovery Foundation
Asceneuron Receives USD 2.2 Million Award from the Alzheimer’s Drug Discovery Foundation
Asceneuron at Genesis Digital 2020
Asceneuron is sharing their experience on discovering innovative and effective therapeutics in the virtual session "Around the World in Neurodegeneration Drug Discovery".
Asceneuron panelist at Tau2020
Asceneuron will take part in a panel discussion at the Tau2020 Global Conference on February 12th-13th in Washington, D.C.